psalexa
logo

Hospital-Acquired Infection Diagnostics Market

Hospital-Acquired Infection (HAI) Diagnostics Market by Product (Reagents and Consumables, Instruments), by Test Type (Immunoassay, Molecular Diagnostics, Urinalysis), by Application (Drug-Resistance, Disease), by Infection Type (UTIs, Surgical Site, Bloodstream, Gastrointestinal Hospital Acquired Pneumonia), by End User (Hospitals, Clinics, ASCs), by Geography (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Japan, China, Australia, South Korea, India, Brazil, Saudi Arabia, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2016–2023

Published: February 2018
Report Code: LS11385
Available Format:
Pages: 176

The research offers market size of the hospital-acquired infection (HAI) diagnostics for the period 2017–2023.

Market Segmentation by Product

  • Reagents & Consumables
  • Instruments

Market Segmentation by Test Type

  • Immunoassay
  • Molecular Diagnostics
  • Urinalysis

Market Segmentation by Application

  • Drug-resistance Testing
  • Disease Testing

Market Segmentation by Infection Type

  • Urinary Tract Infections (UTIs)
  • Surgical Site Infections
  • Bloodstream Infections
  • Gastrointestinal Infections
  • Hospital Acquired Pneumonia
  • Others

Market Segmentation by End User

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Others

Market Segmentation by Geography

  • North America Hospital-Acquired Infection Diagnostics Market
    • By Product
    • By Test Type
    • By Application
    • By Infection Type
    • By End User
    • By Country – U.S., Canada and Mexico
  • Europe Hospital-Acquired Infection Diagnostics Market
    • By Product
    • By Test Type
    • By Application
    • By Infection Type
    • By End User
    • By Country – Germany, France, U.K., Italy, Spain and Rest of Europe
  • Asia-Pacific (APAC) Hospital-Acquired Infection Diagnostics Market
    • By Product
    • By Test Type
    • By Application
    • By Infection Type
    • By End User
    • By Country – Japan, China, Australia, South Korea, India, and Rest of APAC
  • Latin America and Middle East & Africa (LAMEA) Hospital-Acquired Infection Diagnostics Market
    • By Product
    • By Test Type
    • By Application
    • By Infection Type
    • By End User
    • By Country – Brazil, Saudi Arabia, South Africa and Rest of LAMEA

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry